Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04860141 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Jan 2026 to Dec 2026v10
  2. Primary completion date: Mar 2025 to Jan 2026
    • Study completion date: Jul 2025 to Jan 2026
    v9
  3. Primary completion date: Mar 2024 to Mar 2025
    • Study completion date: Jul 2024 to Jul 2025
    v8
  4. Primary completion date: Mar 2023 to Mar 2024
    • Study completion date: Jul 2023 to Jul 2024
    v7
  5. Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Mar 2022 to Mar 2023
    • Study completion date: Mar 2022 to Jul 2023
    v5
  2. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Dec 2021 to Mar 2022
    • Study completion date: Feb 2022 to Mar 2022
    • Start date changed from estimate of Sep 2021 to Jun 16, 2021
  3. Start date: Jun 2021 to Sep 2021v3
  4. Primary completion date: Nov 2021 to Dec 2021
    • Study completion date: Jan 2022 to Feb 2022
    • Start date: May 2021 to Jun 2021
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a double-blind, randomized, prospective, placebo-controlled single-center clinical research study in which 600 mg of gabapentin or placebo will be administered 2 hours preoperatively to 49 patients each undergoing wisdom teeth extraction. We will measure intraoperative opioid use, severity of pain, the number of analgesics taken, and side effect profiles (e.g. nausea/vomiting, dizziness) at the following intervals, 4 hour, 8 hour, 12 hour, 24, and 72 hour post-procedure.
Trial Details
NCT Number NCT04860141
Lead Sponsor Loma Linda University
Conditions
(from sponsor)		 Dental Pain and Sensation Disorder, Pain, Postoperative
Related terms Postoperative Pain, Sensation Disorders, Toothache
Enrollment 98 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov